Intech Biopharm Corporation (TPEX:6461)

Intech Biopharm Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	296.1	198.65	77.73	64.82	220.48	204.69
Short-Term Investments	247.5	60	520	310	115	100
Cash & Short-Term Investments	543.6	258.65	597.73	374.82	335.48	304.69
Cash Growth	26.60%	-56.73%	59.47%	11.73%	10.11%	9.95%
Accounts Receivable	4.21	9.28	3.05	3.67	15.04	4.87
Other Receivables	3.01	9.83	8.7	7.94	7.94	7.78
Receivables	7.22	19.11	11.74	11.6	22.98	12.65
Inventory	146.21	63.86	41.53	51.82	59.87	56.97
Prepaid Expenses	66.02	68.65	43.62	40.7	33.74	35.46
Other Current Assets	0.01	0.06	0.41	0.13	4.26	-
Total Current Assets	763.05	410.32	695.02	479.06	456.33	409.77
Property, Plant & Equipment	1,574	1,885	1,900	2,009	2,090	2,178
Other Intangible Assets	3.35	3.86	4.88	4.8	4.62	4.75
Long-Term Deferred Tax Assets	24.77	24.77	24.77	24.77	24.77	24.77
Other Long-Term Assets	365.7	71.69	86.15	33.17	26.26	4.31
Total Assets	2,731	2,396	2,711	2,551	2,602	2,621
Accounts Payable	15.15	9.82	0.31	1.33	2.4	1.02
Accrued Expenses	-	28.82	19.24	23.71	20.82	19.56
Short-Term Debt	80	-	-	-	-	30
Current Portion of Long-Term Debt	-	248.82	464.65	265.26	211.66	12.89
Current Unearned Revenue	13.13	81.18	78.54	78.31	78.99	81.21
Other Current Liabilities	336.76	18	5.99	5.23	9.35	9.86
Total Current Liabilities	445.04	386.64	568.73	373.82	323.22	154.52
Long-Term Debt	1,143	1,188	970.41	1,143	940.77	1,138
Long-Term Unearned Revenue	8.84	5.53	2.35	-	-	-
Other Long-Term Liabilities	1.77	1.72	1.74	1.54	-	-
Total Liabilities	1,599	1,582	1,543	1,519	1,264	1,293
Common Stock	1,629	1,379	1,374	1,170	1,163	1,007
Additional Paid-In Capital	195.04	19.76	286.16	195.15	481.32	574.58
Retained Earnings	-692.18	-579.76	-488.08	-327.88	-301.76	-250.37
Comprehensive Income & Other	-0.05	-5.16	-4.32	-5.13	-4.72	-2.7
Shareholders' Equity	1,132	814.28	1,168	1,032	1,338	1,329
Total Liabilities & Equity	2,731	2,396	2,711	2,551	2,602	2,621
Total Debt	1,223	1,436	1,435	1,409	1,152	1,181
Net Cash (Debt)	-679.87	-1,178	-837.33	-1,034	-816.94	-876.4
Net Cash Per Share	-4.91	-8.58	-6.95	-8.90	-8.03	-8.74
Filing Date Shares Outstanding	144.43	137.94	137.41	116.96	116.28	100.73
Total Common Shares Outstanding	144.43	137.94	137.41	116.96	116.28	100.73
Working Capital	318.01	23.68	126.3	105.24	133.11	255.25
Book Value Per Share	7.84	5.90	8.50	8.82	11.50	13.19
Tangible Book Value	1,129	810.42	1,163	1,027	1,333	1,324
Tangible Book Value Per Share	7.81	5.87	8.46	8.78	11.46	13.14
Land	-	919.87	919.87	950.72	950.72	950.72
Buildings	-	791.07	790.24	798.32	810.2	809.13
Machinery	-	724.87	657.12	645.9	633.52	616.6

Source: S&P Global Market Intelligence. Standard template. Financial Sources.